AMY RUTHERFORD: Open Payments
NPI 1902281389 · NEW SMYRNA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$374 in 23 payments from 8 companies in 2025. Trend: 2023 $611 · 2024 $582 · 2025 $374
Food & beverage: $374
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 14 | $184 |
| GENZYME CORPORATION | 2 | $49 |
| Paratek Pharmaceuticals, Inc. | 2 | $37 |
| Janssen Biotech, Inc. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Galderma Laboratories, L.P. | 1 | $20 |
| ABBVIE INC. | 1 | $15 |
Products named: Bimzelx, DUPIXENT, NUZYRA, TREMFYA, COSENTYX, Sotyktu, NEMLUVIO, SKYRIZI.
Industry payments across FL — which companies pay providers there.
